Like Drug Companies, Big Chipmakers Are Planning To Spend On M&A Instead of R&D |
| November 24, 2015 | November 2015 Bond Updates |
|
Large companies in both sectors are pulling back their risky research and development spending, revamping their operations to focus on efficiency, and looking towards M&A activity to grow their earnings and products. |
| View more at: http://www.forbes.com/sites/antoinegara/2015/11/23/like-drug-companies-big-chipmakers-are-planning-to-spend-on-ma-instead-of-rd/ |
| Related News |
|